Prev Close | 182.79 |
Open | 182.86 |
Day Low/High | 182.17 / 186.60 |
52 Wk Low/High | 112.60 / 187.67 |
Volume | 916.63K |
Prev Close | 182.79 |
Open | 182.86 |
Day Low/High | 182.17 / 186.60 |
52 Wk Low/High | 112.60 / 187.67 |
Volume | 916.63K |
Exchange | NYSE |
Shares Outstanding | 160.56B |
Market Cap | 29.57B |
P/E Ratio | 14.31 |
Div & Yield | N.A. (N.A) |
Understand that the expected Fed rate cut today is not about recent economic performance in the least.
We have more than 1,050 companies reporting quarterly earnings from Monday to Friday, and here are the ones to keep focus on.
As usual, the stocks that bounce back first are the tech stocks with little Chinese exposure and the consumer packaged goods that just demonstrated good numbers.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Cardinal Health and McKesson have similar business models, but they are very different stocks.
Undervalued shares can get even cheaper in the short run but eventually they play catch up, running much higher.
Many see the Fed as done for the year. Never assume. Read the words as they are written.
McKesson is a high-quality name with a very depressed valuation.
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
It becomes difficult for me to tell you where to run in these markets...
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
Buy Cardinal Health and give it time for the market to reassess the industry.
Micron Technology, Intel and Lam Research are good buys on this heat in semiconductors.
Relief is on the way, and there's an inexpensive beneficiary out in California.
Earnings season is already seeing some wacky effects.
A follow-up on my stock pick of the year, McKesson.
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
It's hard to understand the magnitude of the change.
They make more irrational, stupid moves based on nothing than I ever thought possible.
It might look easy now, but it looked easy in 1999, too.
Nothing breeds future investment success like buying in the face of negative headlines.
Nothing breeds future investment success like buying in the face of negative headlines.
The best high-yielding blue chips at discounted prices.
Market is pricing the stock as if the side effects of this report will just go away.
Revenues, cash flow and EPS are higher than ever for Discovery Communications.
An observation: Despite being within 1% of the all-time high in the S&P Index, this week's feature was a number of investment potholes --relatively large sized individual fundamental disappointments followed by marked stock price drops. Celgene , B...
The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.
Blockbuster drugs still need companies to deliver them.